Mostrar el registro sencillo del ítem
| dc.contributor.author | Escobar-Álvarez, Y | |
| dc.contributor.author | de-las-Penas-Bataller, R | |
| dc.contributor.author | Pérez-Altozano, J | |
| dc.contributor.author | Ros-Martínez, S | |
| dc.contributor.author | Sabino-Álvarez, A | |
| dc.contributor.author | Blasco-Cordellat, A | |
| dc.contributor.author | Brozos-Vazquez, E | |
| dc.contributor.author | Corral-Jaime, J | |
| dc.contributor.author | García-Escobar, I | |
| dc.contributor.author | Beato-Zambrano, C | |
| dc.date.accessioned | 2025-11-18T09:26:17Z | |
| dc.date.available | 2025-11-18T09:26:17Z | |
| dc.date.issued | 2021-05 | |
| dc.identifier.citation | Escobar Álvarez Y, De Las Peñas Bataller R, Perez Altozano J, Ros Martínez S, Sabino Álvarez A, Blasco Cordellat A, et al. SEOM clinical guidelines for anaemia treatment in cancer patients (2020). Clin Transl Oncol. mayo de 2021;23(5):931-9. | |
| dc.identifier.issn | 1699-048X | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/20703 | |
| dc.description.abstract | Anaemia is defined by the presence of haemoglobin (Hb) levels-<-13 g/dL in men and 12 g/dL in women. Up to 39% of cancer patients present it at the time of diagnosis and up to 40% have iron deficiency. Anaemia causes fatigue, functional deterioration and a reduction in the quality of life; it has also been associated with a poorer response to anti-tumour treatment and lower survival. Basic diagnostic tests for anaemia are simple and should be a routine part of clinical practice. These guidelines review the available evidence on the use of different therapies for treating anaemia: erythropoiesis-stimulating agents, iron supplements, and transfusion of blood products. | |
| dc.language.iso | eng | |
| dc.publisher | Springer International Publishing Ag | |
| dc.subject.mesh | Algorithms | |
| dc.subject.mesh | Anemia/blood/complications/diagnosis/therapy | |
| dc.subject.mesh | Anemia, Iron-Deficiency/complications/diagnosis | |
| dc.subject.mesh | Diagnosis, Differential | |
| dc.subject.mesh | Dietary Supplements/adverse effects | |
| dc.subject.mesh | Erythrocyte Transfusion/adverse effects/methods | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Hematinics/adverse effects/therapeutic use | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Iron/administration & dosage/adverse effects | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Medical Oncology | |
| dc.subject.mesh | Neoplasms/complications/mortality | |
| dc.subject.mesh | Quality of Life | |
| dc.subject.mesh | Societies, Medical | |
| dc.subject.mesh | Spain | |
| dc.title | SEOM clinical guidelines for anaemia treatment in cancer patients (2020) | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 33768441 | |
| dc.relation.publisherversion | https://link.springer.com/10.1007/s12094-021-02580-2 | |
| dc.identifier.doi | 10.1007/s12094-021-02580-2 | |
| dc.journal.title | Clinical & Translational Oncology | |
| dc.identifier.essn | 1699-3055 |